Medicus Pharma (MDCX) announces that its phase 2 clinical study, SKNJCT-003, which is currently underway in nine clinical sites in United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback